Limited potential of hepatic arterial infusion of irinotecan

Journal of Chemotherapy

Volumn 16, Issue SUPPL. 5, 2004, Pages 48-50

  De Jong, Floris A ^a   Mathijssen, R H J ^a   Verweij, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hepatic arterial infusion; Irinotecan; Pharmacokinetics

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTIBIOTIC AGENT; DRUG METABOLITE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

BLOOD TOXICITY; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DIARRHEA; DRUG HALF LIFE; DRUG INFUSION; DRUG METABOLISM; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; METASTASIS; PHARMACODYNAMICS; TOXICITY;

EID: 11144231396     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009x.2004.11782384     Document Type: Conference Paper

References (10)

1. Gill S, Thomas RR, Goldberg RM. Review article: colorectal cancer chemotherapy. Aliment Pharmacol Ther 2003; 18:683-92.
2. Chan R, Kerr D. Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003. Curr Opin Oncol 2004; 16:378-84.
3. Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 2003; 8:553-66.
4. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer 1996; 78:1639-45.
5. Mathijssen RH, van Alphen RJ, Verweij J, et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res 2001; 7:2182-94.
6. Mathijssen RH, Verweij J, Loos WJ, et al. Irinotecan pharmacokinetics- pharmacodynamics: the clinical relevance of prolonged exposure to SN-38. Br J Cancer 2002; 87:144-50.
7. van Riel JM, van Groeningen CJ, Kedde MA, et al. Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study. Clin Cancer Res 2002; 8:405-12.
8. van Riel JM, van Groeningen CJ, de Greve J, et al. Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann Oncol 2004; 15:59-63.
9. Fiorentini G, Rossi S, Dentico P, et al. Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study. Tumori 2003; 89:382-4.
10. Bonetti A. Hepatic artery infusion for liver metastases from colorectal cancer. Lancet 2003; 361:358-9.